Before she was the editor of our luxury magazine HTSI, Jo Ellison was features editor at British Vogue, which means that throughout her career she’s had a front-row view of the fashion industry’s love of thinness. In recent years, fashion began to embrace more diversity in body shapes and sizes. But with the rise of Ozempic and other GLP-1 weight-loss drugs, Jo is seeing the industry fear fat again. She worries that as Ozempic becomes more mainstream, fashion will come full circle, back to placing a premium on rail-thin bodies and judging those who don’t conform. Today, she talks about what this could mean for beauty standards, and how it may trickle down to the rest of us. -------We love hearing from you. Lilah is on Instagram @lilahrap, and email at lilahrap@ft.com. And we’re grateful for reviews on Apple and Spotify!-------Links (all FT links get you past the paywall):– Jo’s column about the silence around weight loss in fashion is here: https://on.ft.com/3ZWoDDq– Check out our colleague Brooke Masters’ recent column on how GLP-1 drugs are changing gym regimens and food industry planning: https://on.ft.com/4050Cdl– Jo is on Instagram @jellison22-------Special FT subscription offers for Life and Art podcast listeners, from 50% off a digital subscription to a $1/£1/€1 trial, are here: http://ft.com/lifeandart-------Original music by Metaphor Music. Mixing and sound design by Breen Turner and Sam Giovinco. Clips this week courtesy of Capitol. Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.
